MINK1 activators belong to a specialized class of chemical compounds designed to modulate the activity of the Misshapen-like kinase 1 (MINK1) protein. MINK1 is a serine/threonine kinase that plays a critical role in intracellular signaling pathways involved in cell growth, proliferation, and cytoskeletal dynamics. Specifically, it is a component of the Hippo signaling pathway, a conserved signaling cascade that regulates organ size, tissue homeostasis, and cell fate determination. MINK1 is known to phosphorylate downstream targets, including LATS1/2 kinases and the transcriptional co-activator YAP, which ultimately governs cell proliferation and tissue development. MINK1 activators are designed to interact with MINK1, potentially influencing its kinase activity or its binding affinity to other pathway components. Mechanistically, these activators can modulate the Hippo signaling pathway, impacting cell growth, proliferation, and cytoskeletal rearrangements.
Research on MINK1 activators is instrumental in advancing our understanding of the molecular mechanisms that govern cell signaling and tissue development. Scientists in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact MINK1's function and their downstream effects on cell behavior and tissue homeostasis. The Hippo pathway is a central regulator of organ size and tissue regeneration, with implications in various physiological and pathological processes, including cancer. By exploring the role of MINK1 activators, researchers gain insights into the intricate regulatory networks that underlie tissue growth and development, deepening our understanding of the molecular basis of organogenesis and cell fate determination. These activators serve as powerful tools for investigators seeking to decipher the molecular cues and regulatory mechanisms governing cellular behavior, ultimately contributing to our understanding of tissue biology and its role in health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
As a p38 MAPK inhibitor, SB203580 might modulate MAPK signaling pathways, which could influence MINK1 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP can activate multiple signaling pathways, possibly influencing MINK1 expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
As a Rho-associated protein kinase (ROCK) inhibitor, Y-27632 might influence cytoskeletal remodeling and related pathways, potentially affecting MINK1 expression. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
FGFR inhibitor. By modulating FGFR signaling, PD173074 could impact pathways regulating MINK1 expression. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
As a Wnt production inhibitor, IWP-2 might influence Wnt signaling pathways, which could have downstream effects on MINK1 expression. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
BMP signaling pathway inhibitor. BMP signaling might intersect with pathways regulating MINK1, and its inhibition could alter MINK1 expression. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
A kinase inhibitor that primarily targets c-Raf. Given the interplay of various kinases in cellular signaling, this compound might influence MINK1 expression. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
As a GSK-3 inhibitor, BIO could influence Wnt/β-catenin signaling and other pathways, potentially impacting MINK1 expression. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
p38 MAPK inhibitor. VX-745 could modulate MAPK signaling, potentially influencing the expression of MINK1. | ||||||